133 related articles for article (PubMed ID: 15995621)
1. [Current situation and future of gastric cancer screening examinations: from the viewpoint of gastric X-ray screening].
Kitagawa M
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2005 Jun; 61(6):881-6. PubMed ID: 15995621
[TBL] [Abstract][Full Text] [Related]
2. Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels--The ABC Method.
Yamaguchi Y; Nagata Y; Hiratsuka R; Kawase Y; Tominaga T; Takeuchi S; Sakagami S; Ishida S
Digestion; 2016; 93(1):13-8. PubMed ID: 26789514
[TBL] [Abstract][Full Text] [Related]
3. The Japanese guidelines for gastric cancer screening.
Hamashima C; Shibuya D; Yamazaki H; Inoue K; Fukao A; Saito H; Sobue T
Jpn J Clin Oncol; 2008 Apr; 38(4):259-67. PubMed ID: 18344316
[TBL] [Abstract][Full Text] [Related]
4. Frequency of Helicobacter pylori -negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy.
Ono S; Kato M; Suzuki M; Ishigaki S; Takahashi M; Haneda M; Mabe K; Shimizu Y
Digestion; 2012; 86(1):59-65. PubMed ID: 22722747
[TBL] [Abstract][Full Text] [Related]
5. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ
Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597
[TBL] [Abstract][Full Text] [Related]
6. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
7. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Bostick RM; Wu X; Yuan Y
Am J Gastroenterol; 2017 May; 112(5):704-715. PubMed ID: 28323271
[TBL] [Abstract][Full Text] [Related]
8. The ABC Method and Gastric Cancer: Evidence From Prospective Studies.
Sasazuki S
J Epidemiol; 2016 Dec; 26(12):611-612. PubMed ID: 27546709
[No Abstract] [Full Text] [Related]
9. Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: changes in the risk with extended follow-up period.
Knekt P; Teppo L; Aromaa A; Rissanen H; Kosunen TU
Int J Cancer; 2006 Aug; 119(3):702-5. PubMed ID: 16496404
[TBL] [Abstract][Full Text] [Related]
10. [Strategies for extermination of gastric cancer from Japan].
Asaka M
Nihon Rinsho; 2011 Jan; 69(1):173-82. PubMed ID: 21226280
[TBL] [Abstract][Full Text] [Related]
11. Update version of the Japanese Guidelines for Gastric Cancer Screening.
Hamashima C;
Jpn J Clin Oncol; 2018 Jul; 48(7):673-683. PubMed ID: 29889263
[TBL] [Abstract][Full Text] [Related]
12. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
13. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
[TBL] [Abstract][Full Text] [Related]
14. The new modified ABCD method for gastric neoplasm screening.
Park CH; Kim EH; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
Gastric Cancer; 2016 Jan; 19(1):128-35. PubMed ID: 25663259
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma.
Kokkola A; Louhimo J; Puolakkainen P; Alfthan H; Haglund C; Rautelin H
World J Gastroenterol; 2005 Feb; 11(7):1032-6. PubMed ID: 15742409
[TBL] [Abstract][Full Text] [Related]
16. Serum pepsinogen and gastric cancer screening.
Mukoubayashi C; Yanaoka K; Ohata H; Arii K; Tamai H; Oka M; Ichinose M
Intern Med; 2007; 46(6):261-6. PubMed ID: 17379991
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of IgG antibody titer against Helicobacter pylori.
Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
Helicobacter; 2009 Jun; 14(3):231-6. PubMed ID: 19702853
[TBL] [Abstract][Full Text] [Related]
18. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm.
Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
J Dig Dis; 2014 Jun; 15(6):293-8. PubMed ID: 24602176
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of serum pepsinogen test for screening of gastric cancer].
Nishizawa M; Shiga T; Hayashi M
Nihon Rinsho; 2001 Apr; 59 Suppl 4():538-42. PubMed ID: 11424441
[No Abstract] [Full Text] [Related]
20. [Roles of pepsinogen test, ABC method and barium X-ray examination on gastric cancer screening].
Nakajima S
Nihon Shokakibyo Gakkai Zasshi; 2013 Feb; 110(2):225-33. PubMed ID: 23381210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
